FDA Approves Opdivo Plus Yervoy® for Untreated MSI-H or dMMR Metastatic Colorectal Cancer Bristol Myers Squibb today announced a major milestone in cancer immunotherapy with the U.S. Food and Drug…
Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses In a major step toward transforming the landscape of vaccine development and delivery, Ethris, a clinical-stage biotechnology company…
Avenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market Avenacy Launches FDA-Approved Propofol Injectable Emulsion, USP in the United States: A Milestone in Critical Care and Anesthesia Access Avenacy,…
Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise,…
Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on the discovery and development of innovative therapies that modulate…
Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful…
Verge Genomics Identifies Digital Biomarkers for Early ALS Progression in VRG50635 Trial Verge Genomics, a trailblazer in AI-powered drug discovery and development, today announced pivotal findings that could reshape the…
Flatiron Health Partners with Massive Bio to Strengthen Patient Identification and Services In a strategic move poised to reshape the landscape of oncology clinical research, Flatiron Health, a leading health…
Hello Heart Launches Smart Pill Box to Transform Medication Adherence In a significant step forward for digital heart health management, Hello Heart, the leading digital platform for preventive heart care,…
EU Approves Expanded Use of KAFTRIO for Cystic Fibrosis Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced a significant milestone in the ongoing fight against cystic fibrosis (CF). The European Commission…
Prollenium Announces Leadership Transition Prollenium Medical Technologies (“Prollenium” or “the Company”), a leading innovator in the aesthetic medical space, has announced a significant leadership change as Ario Khoshbin, its Founder…
Sentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences Ltd. (“Zydus…